Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.
https://ift.tt/eA8V8J
https://ift.tt/eA8V8J
Be connected for latest news...
Comments
Post a Comment